A Study to Investigate Andexanet Dosing and the Interaction Between Andexanet and Subsequent Enoxaparin in Healthy Participants

NCT07312851 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

186

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants

Interventions

DRUG: Andexanet alfa
DRUG: Rivaroxaban
DRUG: Apixaban
DRUG: Enoxaparin
OTHER: Placebo

Sponsor

AstraZeneca

Collaborators

[object Object]